跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
洪 裕強
教授
中醫學系
h-index
h10-index
h5-index
1725
引文
23
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1123
引文
17
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
196
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2024
每年研究成果
概覽
指紋
網路
研究成果
(80)
類似的個人檔案
(1)
指紋
查看啟用 Yu-Chiang Hung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Traditional Chinese Medicine
84%
Taiwan
81%
Chinese Herbal Compound
68%
Laser Acupuncture
58%
Population-based Study
44%
Randomized Controlled Trial
40%
Chinese Herbal Medicine
39%
Salvia Miltiorrhiza
35%
Western Medicine
35%
Acupuncture
32%
Traditional Chinese Medicine Treatment
31%
National Health Insurance Research Database (NHIRD)
31%
Functional Proteomics
29%
Ischemic Heart Disease
29%
National Cohort Study
27%
Oxidative Stress
26%
Acupuncture Therapy
26%
Diagnostic Ratios
23%
Electroacupuncture
22%
Meta-analysis of Randomized Controlled Trials
21%
Tanshinone IIA
21%
Aqueous Extract
21%
Current Response
21%
Tongue Diagnosis
21%
Opioid Use Disorder
21%
Therapeutic Effect
20%
Ischemic Stroke
19%
Complementary Therapies
18%
Methadone Maintenance Treatment
18%
Electrical Stimulation
16%
Danshen
16%
Cardiovascular Disease
16%
Apoptosis
16%
Meta-analysis
16%
Randomized Controlled Study
16%
Case-controlled
15%
Population-based Cohort Study
15%
Endothelial Dysfunction
15%
Antioxidant System
15%
Chinese Medicine
15%
Chemotherapy
14%
Childhood Asthma
14%
Dry Eye
14%
Acute Ischemic Stroke
14%
Gene Expression Changes
14%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
14%
Salviae Miltiorrhizae Radix Et Rhizoma
14%
Chronic Kidney Disease
14%
Cirrhotic Patients
14%
Retrospective Analysis
14%
Medicine and Dentistry
Traditional Chinese Medicine
100%
Herbal Product
48%
Randomized Controlled Trial
46%
Laser Acupuncture
43%
Salvia Miltiorrhiza
39%
Chinese Herbal Medicine
39%
Acupuncture
38%
Cohort Analysis
38%
Apoplexy
35%
Oxidative Stress
30%
Ischemic Heart Disease
29%
Observational Study
24%
Medicine
24%
Brain Ischemia
21%
Tongue
21%
Opioid Abuse
21%
Proteomics
21%
Meta-Analysis
21%
Diseases
20%
Diamorphine
20%
Combination Therapy
19%
Maintenance Therapy
18%
Methadone Treatment
18%
Complementary Therapy
17%
Cardiovascular Disease
17%
Massage
16%
Endothelial Dysfunction
15%
Asthma
15%
Odds Ratio
15%
Dry Eye
14%
Gene Expression
14%
Tanshinone IIA
14%
Non Small Cell Lung Cancer
14%
Chronic Kidney Disease
14%
Programmed Cell Death
11%
Antioxidant
11%
Quality of Life
11%
Outpatient
11%
Student T Test
11%
Therapy Effect
10%
Visual Analog Scale
10%
Chinese Herb
10%
Survival Rate
10%
Logistic Regression Analysis
10%
Placebo
10%
Clinical Study
10%
Mitochondrion
10%
Lung Cancer
9%
Analgesia
9%
Combination Chemotherapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Traditional Chinese Medicine
96%
Salvia Miltiorrhiza
56%
Cohort Study
38%
Randomized Controlled Trial
38%
Diseases
38%
Antioxidant
27%
Ischemic Heart Disease
21%
Tanshinone IIA
21%
Laser Acupuncture
21%
Cerebrovascular Accident
21%
Inflammation
19%
Combination Therapy
17%
Cardiovascular Disease
15%
Endothelial Dysfunction
15%
Asthma
15%
Congestive Heart Failure
14%
Brain Ischemia
14%
Diamorphine
14%
Chronic Kidney Failure
14%
Herb
14%
Reactive Oxygen Metabolite
13%
Proteome
13%
Anti-Inflammatory Drug
12%
Methadone
12%
Chemotherapy
11%
Raspberry
10%
Comorbidity
10%
Clinical Trial
10%
Malignant Neoplasm
9%
Breast Cancer
8%
Clinical Study
8%
Uterine Cervix Cancer
8%
Polyphenol
8%
Disease Exacerbation
8%
Prednisolone
8%
Therapeutic Effect
7%
Placebo
7%
Willow
7%
Uterine Cervix Carcinoma
7%
Parkinson's Disease
7%
Red Yeast Rice
7%
Systemic Lupus Erythematosus
7%
Hyperthyroidism
7%
Wilson's Disease
7%
Non Small Cell Lung Cancer
7%
Atrial Fibrillation
7%
Antrodia camphorata
7%
Fibrinogen
7%
Chronic Obstructive Lung Disease
7%
Female Infertility
7%
